They showed that miR-138 can educate CD4+ T cells by downregulating two immune checkpoints, programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte-associated molecule 4 (CTLA-4), resulting in 43% increase in median survival time in GBM tumor bearing mice10. Here, CTLA4 is linked to glioblastoma.